|
|
|||
|
||||
Overview70-chapter authoritative reference that covers therapeutic monoclonal antibody discovery, development, and clinical applications while incorporating principles, experimental data, and methodologies. First book to address the discovery and development of antibody therapeutics in their entirety. Most chapters contain experimental data to illustrate the principles described in them. Authors provide detailed methodologies that readers can take away with them and use in their own laboratories. Full Product DetailsAuthor: Zhiqiang An (Director of Vaccines & Biologics Research, Merck Research Laboratories, West Point, PA) , William R. StrohlPublisher: John Wiley & Sons Inc Imprint: John Wiley & Sons Inc Dimensions: Width: 18.00cm , Height: 4.80cm , Length: 25.40cm Weight: 1.769kg ISBN: 9780470117910ISBN 10: 0470117915 Pages: 928 Publication Date: 27 October 2009 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Out of stock The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsReviewsAuthor InformationZHIQIANG AN, PHD, is the Chief Scientific Officer of Epitomics, Inc., in Burlingame, California. Previously, he was Director of Biologics Research at Merck Research Laboratories, West Point, Pennsylvania. Dr. An started his biotech/pharmaceutical career at Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts. He received a doctor of philosophy degree from the University of Kentucky, Lexington, followed by postdoctoral training at the University of Wisconsin–Madison. Tab Content 6Author Website:Countries AvailableAll regions |
||||